Navigation Links
Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
Date:8/8/2011

ALISO VIEJO, Calif., Aug. 8, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Dr. Joao Siffert to the position of senior vice president research and development. In this newly created role, Dr. Siffert will be responsible for leading all of the company's research and development activities.

"We are thrilled to have another leader of Joao's caliber join the Avanir team," said Keith A. Katkin, president and CEO of Avanir. "His depth of medical knowledge and experience in developing novel neurologic therapeutics will be essential as we look to expand our pipeline. Joao will help propel our initiatives through both follow-on indications of NUEDEXTA and the potential in-licensing of further products to treat central nervous system disorders of high unmet need."

Dr. Siffert previously served as vice president and chief medical officer at Ceregene, Inc., a biotechnology company focused on the development of neurotrophic gene therapies for Alzheimer's and Parkinson's diseases. Prior to this position he served as the chief medical officer at Avera Pharmaceuticals, a CNS specialty pharma company. Prior to joining Avera, Dr. Siffert held positions with Pfizer as the worldwide medical team leader of Lyrica and Neurontin focusing in areas of pain and epilepsy and as medical director for Relpax. He was instrumental in the Phase 3b/4 program development and global launch of Lyrica. Prior to Pfizer, Dr. Siffert held academic positions at Beth Israel Medical Center, where he served as director of the Adult Neuro-Oncology program, and Albert Einstein College of Medicine, where he was assistant professor of neurology. During his tenure at Beth Israel, Dr. Siffert was actively involved in clinical research of novel therapies for patients with brain and spinal cord tumors. He completed residencies in pediatrics at New York Universit
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
2. Avanir Pharmaceuticals Provides Update on European Regulatory Filing for NUEDEXTA
3. Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
4. Avanir Pharmaceuticals Reports Fiscal 2011 Second Quarter Results
5. Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
6. Avanir Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
7. Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
8. Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting
9. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Israel , March 30, 2015 ... Dr. Yuval Avni as the company,s new ... at Giza VC, a leading early stage Israeli venture ... clinical experience in general and vascular surgery.   ... also announced today that Sherpa Innoventures is Beta-O2,s newest ...
(Date:3/30/2015)... March 30, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapeutics primarily in the ... medical needs, today reported its financial results for ... 2014, and provided a business update. ... "The past year has seen a steady growth ...
(Date:3/30/2015)... China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ... chain in China based on the number of ... results for the fourth quarter and fiscal year ... quarter ended December 31, 2014: , Same store ... quarter of 2013 , Revenue increased by ...
Breaking Medicine Technology:Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 2RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 3RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 4RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 5RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 6RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 7RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 8RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 9RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 10China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 11China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 12China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 13China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 14China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 15
... Feb. 19, 2011 CompanDX Ltd., bioinformatics partner ... Laboratory, Inc. (CRL), provider of laboratory testing services ... they entered into a multi-year agreement to collaborate ... and companion diagnostic development for pharmaceutical, biotech and ...
... Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is ... Sodium, USP, 3 mg Tablets to include additional products ... May 17, 2010 and November 17, 2010.  The company ... a single bottle labeled as Jantoven® Warfarin Sodium, USP, ...
Cached Medicine Technology:CompanDX Ltd. and Clinical Reference Laboratory, Inc. Sign Multi-Year Deal in Support of Collaborative Gene Signature and Companion Diagnostic Development 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 3
(Date:3/30/2015)... 30, 2015 V/NO (Virtually No Alcohol) Wines ... flute for opening/closing and for reuse. Consumers simply twist the ... Health-conscious New Yorkers, professionals, and basically anyone can now enjoy ... to kick back socially or pair with meals at work, ... is dealcoholized wine and that means Napa Wine grapes ...
(Date:3/30/2015)... San Clemente, CA (PRWEB) March 30, 2015 ... its organization as a Surety Bond Representative. Richard has been ... for over a decade. , Richard attended the University of ... spanning nearly four decades in the sales and sales management ... Fortune 500 companies. , Most recently, Richard was a ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Considered to ... compliance (GRC) in the global business community, this next ... ups the ante by managing big data and frameworks ... with the already powerful analytic and logic features are ... Peters, CEO of Lazarus Alliance said “The IT Audit ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 ... recognized designer and manufacturer of ergonomic seating ... upholstery options. The new upholsteries bolster the ... and custom seating, providing disinfectable, green choices. ... by renowned textile purveyor CF Stinson. Six ...
(Date:3/29/2015)... Pro Ace Care Heating & Mechanical Ltd has ... HVAC technicians that will visit the customer’s doorstep and ... throughout Vancouver, North Vancouver, Burnaby, Richmond, Surrey, and Langley. ... require regular maintenance from a professional. If you have ... suggest you have it serviced annually by a qualified ...
Breaking Medicine News(10 mins):Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2
... effective treatment for lowering cholesterol, are widely used ... large clinical trials. Although side effects are usually ... have been reported. Tendon impairment has been reported ... studies. A new study published in the March ...
... Year 2007 Highlights, - Revenue for the fourth quarter was $469.5 ... year was $1.8 billion, a 40% ... - Average occupancy for the fourth quarter was 90.6% and for the full ... from 90.4% for the full year of 2006., - Same store Facility ...
... cancers for three receptors could help doctors predict the ... published in the open access journal Breast Cancer Research ... estrogen receptor (ER), progesterone receptor (PR) and human epidermal ... be most at risk from developing brain metastases. Survival ...
... House,Foreign Affairs Committee passed by voice vote the ... Tuberculosis, and,Malaria Reauthorization of 2008., Tony Perkins, ... "I applaud the House Foreign Affairs Committee ... contained in earlier drafts. Previous,drafts would have funded ...
... and, 50-Year- Old Victim,s Own College Summer Employment at GM Facilities ... to Mesothelioma Attorneys Levy Phillips & Konigsberg, ... ... "take home" asbestos,fibers on work clothes his father and brother wore while ...
... increases 88% and net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, ... or "Our") (NYSE:,DR) today announced its financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross ...
Cached Medicine News:Health News:Tendon complications, though rare, linked to statins 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 3Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 4Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 5Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 6Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 7Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 8Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 9Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 10Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 11Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 12Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 13Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 14Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 15Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 16Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 17Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 18Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 19Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 20Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 21Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 22Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 23Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 24Health News:Breast cancer subtypes linked to survival from secondary brain tumors 2Health News:$30.3 Million Jury Verdict Believed to Be New Jersey's Largest 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 7
...
...
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
Medicine Products: